BioSpace News Archive

Policy

Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter

Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation and ventricular tachycardia, announced the completion of enrollment in its Cryocure-VT trial of ultra-low temperature cryoablation for the treatment of monomorphic ventricular tachycardias.

May 3, 2023
·
3 min read
Genetown

Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering

Morphic Holding, Inc., a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, announced the pricing of an underwritten public offering of 5,333,334 shares of its common stock at a price to the public of $45.00 per share.

May 3, 2023
·
4 min read
Pharm Country

OKYO Pharma Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2023) in San Diego, CA, May 5-8, 2023

OKYO Pharma Limited announced that two presentations will be given on OK-101 at the American Society of Cataract and Refractive Surgery in San Diego, CA, May 5-8, 2023.

May 3, 2023
·
2 min read
Business

Vaccentis Appoints Dr. Ingrid Rauter as Chief Medical Officer and Head of Research & Development

Zurich, Switzerland, May3, 2023 - Vaccentis AG, a clinical-stage Swiss biopharmaceutical company developing patient-individualized medicines, announced the appointment of the experienced life science executive Ingrid Rauter as Head of R&D and Chief Medical Officer.

May 3, 2023
·
3 min read
Business

Occlutech Year-end Report 2022 - Significant Uptick in Sales Growth as Transformation Processes are Reaching an End

Occlutech Holding AG is a leading specialist provider of minimally invasive structural heart implants.

May 3, 2023
·
5 min read
Biotech Bay

Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network of Lab Partners

Mainz Biomed NV announced that it has added Eurofins GeLaMed to its network of lab partners offering PCR test kit processing of ColoAlert®, its flagship product that is a highly efficacious and easy to use at-home screening test for colorectal cancer.

May 3, 2023
·
5 min read
Business

Photocure ASA: Invitation to presentation of first quarter 2023 financial results

Photocure ASA will announce the first quarter 2023 financial results on Wednesday 10 May 2023 at 08:00 CEST and will present a live webcast at 14:00 CEST the same day.

May 3, 2023
·
1 min read
BioCapital

QIAGEN welcomes U.S. Preventive Services Task Force reaffirmation for latent TB screening in populations at increased risk

QIAGEN announced that it welcomed the U.S. Preventive Services Task Force reaffirming a previously issued recommendation for latent tuberculosis infection screening by primary care physicians in populations at increased risk.

May 3, 2023
·
6 min read
Drug Development

Lilly’s Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer’s Disease

Eli Lilly and Company announced positive results of the TRAILBLAZER-ALZ 2 Phase 3 study showing that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease.

May 3, 2023
·
11 min read
Business

United Therapeutics Corporation Reports First Quarter 2023 Financial Results

United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended March 31, 2023.

May 3, 2023
·
10 min read